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Covalent binding of [7..3H]styrene (S) to DNA in vivo was 
measured and evaluated in a quantitative manner in order 
to investigate whether DNA adduct fonnation could form a 
mechanistic basis for twnor induction in a carcinogenicity 
bioassay. [7..3H]S was administered by inhalation in a closed 
chamber to male and female CD rats and B6C3Fl mice. After 
4.5-6 b (rats) and 6-9 h (pools of four mice), S. doses of 
23-39 and 85-110 mg/kg respectively had been metaboHzed. 
DNA was purified to constant specific radioactivity which was 
m(2turable in all samples. D~A was enzymatically degraded 
to tbe 3'-nucleotides which were separated by HPLC for the 
detection of radiolabeled nucleoöde-S adducts. The fractions 
witb the nonnal nucleotides contained most of the 
radioactivity. In mouse Ii ver DNA, a minute but significant 
Ievel of adduct radioactivity was also detected. In tbe units 
of the Covalent Binding Index CBI = (;Lmol adduct/mol DNA 
nucleotide)/(mmol chemicallkg body wt), values ofO.OS-0.09 
and 0.07-0.18 were calculated for males and fernales 
respectively. In the rat, no DNA adducts were detectable in 
tbe liverat a Iimit of detection of 0.1 CBI units. Two of the 
four lung samples of the female rats sbowed adduct-related 
radioactivity corresponding to 0.07 CBI units. The CBI values 
are compatible with styrene 7 ,8-oxide as the reactive 
intennediate. The d.ata are compared with CBI values and 
carcin'ogenic potencies of established genotoxic carcinogens. 
It is concluded that tbe DNA-binding potency of S is so low 
that significant tumor induction in a standard bioassay for 
carcinogenicity is unlikdy tobe due to DNA adduct fonnation 
alone. Consequences for a human risk estimation are 
discussed. 
Introduction 
Styrene (S•; vinyl benzene; C~5-CH=CH2) is widely used 
for the manufacture of polymers and reinforced plastics. High-
level exposure of humans to S can occur by inhalation at the 
workplace; low-level exposure is due to smoking and air pollution 
(1). Exposure toS migrating from packaging into food appears 
to be negligible (2). 
Epidemiological studies investigated the carcinoge~c potential 
of S in humans (reviewed in 3). An insignificantly elevated Ievel 
of Iymphatic and hematopoietic cancer was reported in some of 
the older studies which were based on mixed chemical exposures, 
including benzene. The two most recent studies, on the other hand, 
showed a decrease in these n.unor types. Carcinogenicity of S was 
investigated in nine long-tenn animal studies. At very high dose 
•Abbrevladoos: S, styrene; CBI. covalent binding i.nde.x = DNA adduct 
Ievel/dose = {ltmol adductlmol DNA nucleotide)/(mmol chemicallkg body wt); 
SO, styrene 7,8-oxide. 
Ievels, S appeared to affect the Jung and the liver in the mause 
and the mammary gland in the rat, i.e. organs with high 
spontaneous twnor incidence. However, all these sturlies bad ~ 
deficiencies or limitations (e.g. toxicity), so that the InternatiOnal 
Agency for the Research on Cancer (IARC) considered the 
evidence of carcinogenicity in animals to be limited (4). 
Mutagenicity of S has been reviewed by Barale (5). In vitro, 
S was occasionally found to be mutagenic, exclusively with 
metabolic activation. In animals, S was very weakly genotoxic 
(6). In humans, positive and negative cytogenetic studies were 
reported (5). Detectable effects appeared to be limited to 
workplace exposure Ievels >50 p.p.m. (7). 
Covalent binding of S to DNA was investigated in the mouse 
after i.p. injection (8). The DNA-binding potency expressed in 
the units of the Covalent Binding Index (CBI) for liver DNA 
was between 2 and 5; this is in the potency range of wea.kly 
genotoxic carcinogens (9). It was therefore considered importaßt 
to reinvestigate the DNA-binding potency of S. 
In this study, covalent binding of tritiated S to DNA was 
investigated in rat and rnouse by inhalation, and the data were 
analyzed in terms of a DNA-binding potency. The results were 
compared with other carcinogens (9) in order to answer the 
question whether DNA adduct formation could fonn the 
mechanistic basis for a putative tumor induction in a 
carcinogenicity bioassay. 
Materials and methods 
Ckmica/s 
Twice 20 mCi (7-3H]S (mol. wt 104.15), containing 10-15 p.p.m. 4-ten-
butylcatechol as stabilizer, we~ purchased in 2 mCi ampoules from The 
Radiochemical Centre, Amersham, UK. The two batches had specific activities 
of 21 mCi/mmol (0.2 mCi/mg) and 20 mCi/mmol (0.19 mCi/mg) and were used 
for the experirnents with the rats and mice respectivcly. The ampou1es were storcd 
at - 20°C in the dark and used within I mon1h after delivery. The radiochc:mical 
purity determined by the supplier immediately prior to shipment was i.ndicatcd 
tobe 92.4 and 89.5% respectively. In order to check whether the [7.lH]S was 
in monomeric fonn when used, the specific activity was checked during the 
inhalation exposures by radio-GC, on a 20 m X0.3 nun column filled with PS 
089 (95% dimethyU5% diphenylpolysiloxan from HOls America, Inc.) and run 
with hydrogen at 50°C. The specific activity indicated by the supplier could be 
confirmcd. 
Animals 
Six male and six female Cri:COS BR rats and 24 male and 24 female 
B6C3FJ/CrlBR mice from Cbarles River Wiga. Sulzfeld, Germany were used. 
They were acclimatized in Macrolon cages for atleast 1 weck aftcr dclivery and 
were fed ad libiJum with tap water and rnaintenance diet NAF AG 890, purchased 
from Nafag AG, Gassau SG, Switz.erland. 
Inhalation aposur~ 
Single rars or groups of four mice (weights given in the tables) were exposed 
to tritiatcd S by inhalation in a closed chamber (10). The chamber consists of 
a 2 I desicca10r with an inlet for oxygen and a sepwm for air sarnpling. Expired 
carbon dioxkle is adsorbcd on sodatime placed in1o the chambet. The resulting 
atmospberic pressure reduction is compensated by an inßux of oxygen with which 
tritiatcd S is carried along. 
The ampoule containing 2 mCi tritiated S (10 mg for ntts, 10.4 mg for the 
pools of four mice) was centrifuged at 2CXX> g for 5 min. cooled at the boUom 
with liquid nitrogen, cut open and i..mmedialely put into the oxygen flow sySlem 
of the inhalation apparatuS. Air samples taken from the chamber were analysed 
by GC for the time course of the S concentrlltion. The exposure was tmninated 
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alterat least four mctabolism balf-lives. Tbe animals were killcd with cther; liver 
aod lung of rats and liver of micc were exciscd, pooled within the inhalation 
groups (mice) and kept frozen at -20°C. The mouse lung was not investigatcd 
because tbe yieJd of DNA would not bave rrsulted in a sarisfactory detcction lim.it. 
Isolaiion of DNA 
DNA was isolarcd via cbromatin prccipiiation according to Sagdsdorff tt al. ( II). 
Repurification to consumt specific activity was carried out as prcviously reported 
(12). 
Control experiments were performcd using DNA isolatcd from untreatcd 
animals. (i) Radioactivity controls were compared with historical values to sbow 
that the work-up of the DNA samples bad been performed without extemal 
comamination wilh radiolabel. (u) An in vitro inc:ubation of a clmmaiin supemaiBDl 
from a treated animal with a chromatinpellet from a control (13) was done to 
investigate wbether radioactive chemieals present in tbe tissue wben the anima1s 
were lcilled could irreversibly a.ssociate with the DNA during work-up. 
HPLC anaJysi.s of DNA 1JJU:/eotidu 
DNA was digestcd to COil8tituent nucleotides according to Sagelsdorff et al. (13). 
The resulting deoxynudeotides were sepanued by HPLC on an Eurosphere RPI8 
SJL column (250x4 mm) witb 2 mVmin 30 mM ammonium formate buffer, pH 
3.812-60% mcthanol grufient system according to Cantoreggi and Lutz (12). 
1be fractions were dried down on a rotatory evaporator aod dissolved in I ml 
water. 
Scinlillarion counting 
DNA samples and nucleotide fractions were counted in 10 m1 Ultima Gold* 
(Packard) in plastic vials for 100 min in a liquid scintillation counter LS 600) 
LL (Beckman, Pullenon CA) equipped with the LowLevel• option (rat liver 
DNA and nucleotidc fractioos). 1be significance Ievel at two Sla!dard deviations, 
given by the Poisson distribution of the radioactive decay plus vial-to-vial 
differences, bad been determined tobe 1.1 c.p.m. in an opcimized trilium clwmel. 
The counting efficiency was between 47 and 52%. 
The net radioactivity was calculated by subtracting the radioactivity of an 
equivalent sample isolllled from anim.als treatcd with unlabeled S, both for DNA 
samples and for fraaions of thc IIIJCleotidc analyses. 
Calcrdalions 
The concentration of a DNA solution was calculaled from the optical density 
of a diluted aliquot at 260 nm using an absorbaoce of 20 for I mg DN A/ml. 
Dcpending on the amount of DNA a'Y8.1lable, an aliquot of 0.25-l mg DNA 
was dilutcd with calcium succinate buffer to a standard.ized concentration (usually 
the concentratioo of the most dilute sample of th.e ongoing experi.ment). 
The conc:enttation of the nuclcotide solutions was calculated from tbe optical 
density of a dilutcd aliquot at 260 nm assuming an ab5orbance of 35 for a lliJC1cot:idc: 
mixture equivalent to 1 mg digested DNA/ml. 
The specific DNA radioactivity wasexpressedas DNA adduct Ievel per dose 
adm.inislercd and con~ to the units ofthe CBI (14), CBI = (pmol adduct/mol 
DNA nucleotide)/(mmol cbemicallkg body wt). Doses are given in the tables. 
Results 
Kinetics of S in the inhalation chamber 
The concentration- time course of S in the chamber was 
characterized by three phases. The first phase was dominated 
by an influx of S into the chamber with maximu.m concentrations 
of274-300 and 385-464 p.p.m. registered after 1-2 hin the 
experiments with rats and pools of mice respecti vely. Equilibriwn 
Table I. Investigation of the covalent binding of [7-3H)styrene to DNA isolated from liver and Jung of male CD rats aft.er inhalation exposure 
Rat no./weight (g) 1/452 21440 3/347 4/437 Sl4l1 6/353 
Dose (mglkg) 20.1 20.7 28.8 22.9 24.3 28.3 
(1010 d.p.m.lkg) in virro control 1.27 1.0 1.07 1.2.5 
incubation 
/.her DNA 
Fim purifictJIÜJn (radioactivity in 
1 mg DNA) 
Total counts (c.p.m.) 21.1 6.8 135.6 251.8 127.2 62.3 
Specific activity (d.p.m.lmg) 27.5 219 442 204 79 
Second purification 
Specific activity (d.p.m.lmg) 128 43 22 47 
1hird purijico.tion (radioactivity in 
0.5 mg DNA) 
Total counts (c.p.m.) 5.7 ~.5 35.9 12.7 10.7 17.4 
Specific activity 
(d.p.m./mg) 129 30 22 50 
(CBI units) 3.1 0.9 0.6 1.2 
Nucleotide analysis 
Radioa.ctivity eluting without 
optical density (%) <3% <13% <19~ <8% 
Covalent DNA binding (CBI units) <0.1 <0.2 <0.2 <0.1 
Lung DNA 
Fim purijicDiion (radioactivity in 
0.2 mg DNA) 
Total COWits (c.p.m.) 9.5 9.6 16.6 23.1 14.5 12.6 
Specific activity (d.p.m./mg) 64 135 49 30 
Second purijicoJiqn (radioactivity in 
0.15-0.2 mg DNA) 
Total cowns (c.p.m.) 9.7 9.8 1.5.2 19.1 13.1 13.6 
Specific activity 
(d.p.m./mg) 74 123 34 39 
(CBI units), 1.8 3.8 1.0 1.0 
Nucleotide analysis 
Radioactivity eluting wilhout 
optical density (%) ND <5% ND <19% 
Covalent DNA binding (CBI units) <0.3 <0.1 
ND, not done (no DNA left). 
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for S between the atmosphere and the animal was reached after 
another 0.5-1 h. Thereafter, the concentration of S in the 
chamber decreased as a result of metabolism. The experiment 
was terminated when the concentration of S in the chamber 
DNA blnding of styrme 
atmosphere bad dropped to between 18 and <5 p.p.m. (42 
p.p.m. forthefemale mouse pool no. 3). This was after 4.5-6 
h with the rats and 6.25-9 h with the mice. Taking into account 
the metabolism half-life deduced from the third phase, > 95% 
Table D. Investigation of the covalent binding of [7-3H]styrene to DNA isola1ed from liver and lung of female CD rats after inhalation exposure 
Rat oo./weight (g) 1/282 21281 31284 4/267 51280 61259 
Dose (mglkg) 32.3 32.4 35.2 37.4 35.7 38.6 
(1010 d.p.m.lkg) invitro control l.S5 1.6S l.S7 1.70 
incubation 
Li-ver DNA. 
Fim purificarion (radioactivity in 
1 mg DNA) 
Total cou.nts (c.p.m.) 10.5 6.7 219 1021 230 116 
Specific activity (d.p.m./mg) 401 1943 422 203 
Secend purijication 
Specific activity (d.p.m./mg) 53 121 61 59 
Third purificarinn (nuhoactivity in 
0.5 mg DNA) 
Total counts (c.p.m.) 5.9 5.7 14.8 18.4 27.3 17.2 
Spccific activity 
(d.p.m./mg) 38 54 91 48 
(CBI units) 0.8 1.0 1.8 0.9 
Nuckotide anaJysis 
Radioactivity eluting without 
optical density (%) <11% <8% <8% <7% 
Covalent DNA binding (CBI units) <0.1 <0.1 <0.2 <0.1 
Lung DNA 
First puri.ficmion (radioactivity in 
0.2 mg DNA) 
Total counts (c.p.m.) 10.3 10.6 18.8 23.0 20.9 36.0 
Spccific activity (d.p.m./mg) 84 124 104 251 
Second pu.rification (radioactivity in 
0.2 mg DNA) 
TotBJ counts (c.p.m.) 9.5 10.0 18.3 23.3 19.5 37.1 
Spccific activity 
(d.p.m./mg) 85 131 96 272 
(CBI units) 1.7 2.5 1.9 4.9 
Nuc/4otide analy.ris 
Radioaaivity eluting without 
optical density (%) 3% 3% <4% <5% 
Specific activity (d.p.m./mg) 3.8 3.6 <4.3 <12.9 
Covalent DNA binding (CBI units) 0.07 0.07 <0.08 <0.23 
cpm 
16 B 
14 
12 
A 10 
cpm 8 
6 
4 
2 
Timeimin 10 20 30 40 Timeimin 
Fig. 1. Rev~-phase HPLC profiles of opticaJ density (solid line) and tritiwn radioa.ctivity (banl; c.p.m.) of deoxynbonuclcotidcs obtaiDcd by enzymatic 
bydrolysis of DNA. (A) From lhe liver of a male Crf:~ BR rat (no. 4), 6 h after i.nha.l.ation of J.Ox 1010 d.p.m.lkg (22.9 mglkg) {7-3H]styrene. (B) From 
the pooled livers of four male 86C3FJ m.ice (pool no. 4), 8 h after inhalstion of 3.9x 1010 d.p.m.lkg (92.4 mglkg) (7-3H]styrene. 
357 
S.Cantoreggl and W .K.Lutz 
of the amount of S put into the system had been metabolized 
within the exposure period. 
DNA binding of [3H]S in the rat 
DNA isolated from the liver and the Jung of the ratswas analyzed 
for radioactivity and nucleotide-S adducts. The results are 
swnmarized in Tables I and Il, for males and females 
respectively. 
In the liver, two rounds of DNA repurification were required 
to remove all reversibly bound radioactivity and obtain constant 
specific activities. All DNA samples were radiolabeled at Ievels 
of 22-129 d.p.m./mg. 
Radioactivity irreversibly associated with the DNA is not 
necessarily due to nucleotide-ca.rcinogen adduct formation, but 
can be the result of biosynthetic incorporation of radiolabet via 
DNA biosynthesis. Tritiated water is formed from the 7-3H 
Iabel of S during metabolism from mandelic acid to 
phenylglyoxylic acid. Tritium from water can then be 
incorporated into the 2' -position of the deoxyribose in the 
ribonucleotide reductase step. 
In order to distinguish adduct formation from radiolabet 
incorporation, nucleotides were analyzed for radioactivity. HPLC 
proftles with rat liver DNA showed that all radioactivity eluted 
with normal nucleotides (Figure 1A). At elution times known 
for S-nucleotide adducts ( 12), no radioactivity was measured at 
a detection Iimit of 1.1 c. p.m. Conversion of th.is detection Iimit 
to the units ofthe CBI showed a maxirnum possible DNA-binding 
potency of CBI < 0.1 for both males (Table I) and females (fable 
li). 
In the rat Jung, only one repurification round was necessary 
to show constant specific DNA radioactivity for all samples. Not 
all samples could be subjected to nucleotide analysis because of 
low DNA yields. For the males (Table I), all detectable DNA 
radioactivity eluted with the natural nucleotides. The Iimit of 
Table m. lnvestigation of the covalent binding of [7-3H)styrene to DNA isolated from the liver of male B6C3F1 rnice after inha1ation exposure 
Mice no./weight (g) 1/117 21120 3/121 4/112 5/118 6/123 
Dose (mglkg) n.6 76.0 86.0 92.4 87.8 84.7 
(1010 d.p.m./kg) in vilro control 3.6 3.9 3.7 3.6 
incubation 
First purification (radioactivity in 
0.35-0.87 mg DNA) 
Total counts (c.p.m.) 10.3 9.6 59.6 82.6 30.1 50.7 
Specific activity (d.p.m./mg) 115 177 116 123 
Second purification (radioactivity in 
O.S mg DNA) 
Total counts (c.p.m.) 10.0 9.6 22.7 30.3 32.5 31.5 
Specific activity 
(d.p.m./mg) 51 80 89 8S 
(CBI units) 0.4 0.6 0.7 0.7 
Nuckoritk analysi.s 
Radioactivity eluting with 
optical density (c.p.m.) 8.6 17.8 18.6 20.1 
Radioactivity eluting without 
optical density (c.p.m.) 2.1 2.6 2.2 1.2 
Specific activity (d.p.m./mg) 9.6 11.6 9.8 5.4 
Covalent DNA binding (CBI units) 0.08 0.09 0.08 o.os 
Table IV. lnvestigation of the covalent binding of [7-3H]styrene to DNA isolated from the liver of female 86C3F1 mice after inhalation exposure 
Mice no./weight (g) 1/88 2194 3195 4195 5/102 6191 
Dose (mg/kg) 103.3 96.9 109.9 109.0 102.1 107.7 
(1010 d.p.m.lkg) in vilro coJUrol 4.6 4.6 4.3 4.5 
incubation 
First purific:ation (radioactivity in 
0.40-0.58 mg DNA) 
Total counts (c.p.m.) 9.3 9.0 68.0 84.3 29.7 75.3 
Specific activity (d. p. m./mg) 295 Jn 101 332 
Second purijicalion (radioactivity in 
0.5 mg DNA) 
Total counts (c.p.m.) 9.6 9.4 60.6 49.4 36.8 49.6 
Spccific aaivity 
(d.p.m./mg) 206 156 107 157 
(CBI units) 1.4 1.0 0.8 1.1 
Nucleoritk analysis 
Radioactivity eluting with 
optical density (c.p.m.) 22.9 33.3 23.4 40.8 
Radioactivity eluting without 
optical density (c.p.m.) 2.5 4.0 2.1 3.0 
Specific activity (d.p.m./mg) 26.6 18.1 9.6 13.6 
Covalent DNA bi.nding (CBI units) 0.18 0.12 0.07 0.09 
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detection of adducts was at CBI <0.1- <0.3. With the females 
(fable m, the yield of DNA was higher. In two samples, the 
radioactivity measured in the fractions known to contain adducts 
(12) was just detectable (CBI = 0.07). 
DNA-binding of [3H]S in the mouse 
DNA was isolated from the pools of four livers. After the first 
repurification, one sample already showed constant specific 
activity and the remaining had only slightly been reduced (Tables 
m and IV). A second repurification was not necessary. HPLC 
analysis of the nucleotides revealed, in all eight samples, a small 
but significant amount of radioactivity in fractions eluting after 
the natural nucleotides (Figure 1 B). The elution time was similar 
to the early-eluting S-nucleotide adduct(s) generated from DNA 
plus SO in vitro (12). Expressed in the units of the CBI, the DNA-
binding potency was at the extremely low Ievel of 0.05-0.09 
and 0.07-0.18 formales and females respectively. The average 
was 0.10 ::1:: 0.04 CBI units. 
Discussion 
S was shown to have a very low DNA-binding potency in vivo 
after inhalation exposure of rodents. Using high Ievels of 
radiolabeled S, the low limit of detection of DNA adducts allowed 
to establish a DNA-binding potency of CBI - 0.1 for mouse 
liver DNA. This very low genotoxic potency is in good 
quantitative agreement with the borderline mutagenicity of S in 
vivo. 
What is the reactive intermediate? Metabolism of S involves, 
to almost 100%, the intermediate formation of the 7,8-epoxide 
(SO). The question is whether this epoxide could be responsible 
for the DNA adduct fonnation seen with S. SO is a relatively 
inert epoxide (15). SO is also wealdy mutagenic in a number 
of test systems without metabolic activation (5). DNA binding 
by SO was not detectable in vivo but the Iimit of detection was 
not as good as in the present experiments with S: a CBI <0.6 
was found for mouse liver after i.p. injection (12). The CBI = 
0. I measured here for S is therefore not in contradiction to the 
negative fmdings with SO. The data are consistent with the idea 
that SO was responsible fol.' the DNA adduct formation seen here 
with S. 
A rninor pathway in S metabolism ( < 1 %) results in the 
formation of 4-vinylphenol (16, 17), probably via the styrene 
3,4-epoxide. The low CBI value of 0.1 does not allow for the 
possibility that this or another metabolic pathway could result 
in high Ievels of DNA adducts. 
The present CBI values for S in mouse liver DNA are 20-50 
times lower than the values that could be derived from another 
report (8). A similar discrepancy was noted in the experiments 
with SO: a CBI value of 2.2 was deduced from Byfält Nordqvist 
et al. (8), while our values were below a Iimit of detection of 
CBI <0.6 under identical experimental conditions (12). ByfaJt 
Nordqvist et al. apparently did not purify the DNA to constant 
specific activity. It cannot be excluded, therefore, that their DNA 
bad not completely been freed from non-covalently bound 
radiolabeled S metabolites. 
Chemical stability of DNA adducts is a prerequisite for a 
correct interpretat:ion of DNA-binding experiments. Evidence that 
this requirement is met comes from V odicka and Hemrninki ( 18) 
who showed a half-life of lO days for SO-DNA adducts at pH 
4.2 and room temperature in double-stranded DNA. Under our 
experimental conditions for the DNA purification (neutral pH, 
temperature mostly 4°C), the half-life could be even longer. 
Furthennore, in the present experiments, DNA could be 
DNA bindlng or stynne 
repurified to constant specific activity. This would not be possible 
with labile adducts. It can therefore be assumed that the adduct 
concentrations measured after DNA purification retlected the 
situation at the time the animals were killed. 
No significant difference was seen between mice and rats or 
between sexes. In the rat liver, the Limit of detection was at CBI 
<0.1 in both males and females (Tables I and m, while the 
highest value seen in the mouse Ii ver was at CBI = 0.09 (male, 
TableIm and CBI = 0.18 (female, Table IV). Therefore, DNA-
binding potency data would not help explain species or sex 
differences tentatively seen in tumor induction (4). 
It has been shown that potencies of genotoxic carcinogens 
correlate quite well with CBI values for liver DNA [r = 0.81 
for 29 activatioiKiependent mutagenic carcinogens (9)]. The range 
of CBI values spanned from 2 to 10 000, carcinogenic potencies, 
expressed as TD50 values, from 8 to O.<XXXXH mmollkg/day. 
Vinyl chloride, to mention one of the data points, had a CBI = 
8 for mouse liver DNA (19) and a TD50 value for 
hemangiosaroomas in the liver of I mmollkg/day (20). 
Using the above correlation of CBI versus TDso, the DNA 
binding potency of S as determined here (CBI = 0.1) extrapolares 
to a TD50 value of -1000 mmol S/kg/day. This is equivalent 
to a dose of - 100 g Slkg/day, required theoretically to induce 
a 50% tumor incidence in a stanclard lifespan if DNA adduct 
formation is the mechanism of carcinogenic action. Thls 
correlation could very tentatively be used to estimate a cancer 
risk in humans, under the assumptions of a linear dose -response 
relationship, the absence of species differences, and 
proportionality with duration of exposure. Exposure of a worker 
f~ 15 years to a daily dose of 10 mg/kg (resulting from an 8 
h exposure at 20 p.p.m. for instance) would result in a theoretical 
cancer risk of 1 in lOS Jives (1 in 2 at 100 glkg/day for life; 1 
'in 20 000 at 10 mg/kg for life; 1 in 100 000 if exposed only 
for one-fifth of the standard human lifespan). 
In conclusion, the Ievel of DNA adduct fonnation by S is highly 
unlikely to become responsible for a significant increase in tumor 
incidence in a bioassay. Changes observed in the spontaneaus 
tumor pattern in standard bioassays with S are more likely due 
to unspecific effects at maximum tolerated dose Ievels. 
Acknowledgements 
We thanlc Dr H.D.Hoffinann, BASF AG, Ludwigshafcn, Germany, for valuable 
discussions. This work was supportcd by ECETOC, the European Chem.ical 
Indusuy Ecology and Toxicology Cerure. 
Refe.rences 
I. WHO (1983) Styrene. Envirorrnrenral Heabh Crit~ria. 26, 1-123. 
2. Wüthrich,C., Müller,F., Blaser,O. and Marek,B. (1985) Die Belastung der 
Bevölkerung mit Pestiziden und anderen Fremdstoffen dun::h die Nahrung. 
Min. ~i~re Lebensm. Hyg., 16, 260-276. 
3.Bond,G.G., Bodner,K.M., Olscn,G.W. and Cook,R.R. (1992) Mortality 
among workers engaged in the devdopment or manufacture of styrene-ba.sed 
products-an upda.te. Scand. J. Wort Environ. HNlJJa, 18, 14S -154. 
4. IARC (I 987) /ARC Monographs on the EvaJwuion of Carcinogenic IWks to 
Human.s, Suppt. 7. IARC, Lyon, pp. 345-347. 
S. Barale,R. (1991) The genetic toxicology of styrene and styrene oxide. Mlllat. 
Ru., 257, 107-126. 
6. Simula,A.P. and Priestly,B.G. (1992) Species diffe:rcnces in the geuoroxicity 
of cyclophosphamide and eyrene in thrce in l'ivo assays. MUlal. Res., 271, 
49-SS. 
7.Sorsa,M., Anttila,A., Järventaus,H., Kubiak,R., Norppa,H., Nylander,L., 
Pelcari,K., Pfiffli,P. and Vainio,H. (1991) Styrene revisitcd~posure 
assessment and risk cstimation in reinforced plastics industty. Prog. Clin. 
Bio/. Re.r., 372, 187-195. 
8. Byfält Nordqvist,M., Loef,A., Osterman-Golbr,S. and WaUes,S.A.S. (1985) 
359 
S.Cantoregi aod W .K.Lutz 
Covalent binding of styrene and styreoe-7 ,8-oxide to plasma proceins, 
hemoglobin and DNA in tbe mouse. Olmt..- Biol. lnteraetions, !S, 63-73. 
9. Lutz,W.K. {1986) Quantitative cvaluation of DNA binding data for risk 
estimation aod for classification of d.im::t and i.ndirect carcioogens. J. Cancu 
Res. Oin. Oncol., lU, BS-91. 
10. Baertsclt,A., Lutz,W.K. BDd Schlatttr,C. (1991) Effi:ct of inha1ation exposure 
regimc-n on DN A binding potc:ncy of 1,2-dkbloroetbane in the rat. A.rr:h. 
Toxicol., 65, 169-176. 
11. Sagdsdorff,P., Lutz, W .K. aod Scblatter, C. (1983) Tbe relevance of covalent 
binding to .mouse liver DNA to the carcinogenic action of 
bexachlorocyclohexane isomers. Carcinogme.ris, 4, 1267-1273. 
12. CanlOreggi ,S. and Lutz, W .K. (1992) Investigation of the covalent binding 
ofStyreno-7,8-oxide to DNA in n11 and mouse. CardrrogeMSi1,13, 193-197. 
13.Sagelsdorff,P., Lutz,W.K. and Scblatter,C. (1988) DNA',methylation in rat 
liver by damirozide, 1,1-dimethylhydrazine, and dimcthylnitrosamine. 
Fundam. A.ppL Taxicol., 11, 723-730. 
14. Lutz,W.K. (1979) In wm covalent binding of organic cbemicals to DNA as 
8 quamitBtive indicator in tbe process of chcmical carcinogcnesis. MUial. RD., 
65, 289-356. 
1S.Betso,J.E., Carreon,R.E. aod Mincr,V.M. (1991) The use ofproton nuclear 
mag:oetic resonance spectroscopy (1H NMR) for monitaring the reaction of 
epoxides with butylamine and predictive capabilities of tbc rdative alkytation 
index (RAI) for skin sensitiz.ation by epoxides. Toxicol. AppL Pharmacol., 
108, 483-488. 
16. Pantaroao,C., Fanelli,R., Bidoli,F., Morazzoni,P., Salmoua,M. and 
Szr:zawinska,K. (1978) Arme oxidcs in styreoe mdilbol.ism, 8 new perspedive 
in styreDe toxicity? Scand. J. Wort. Environ. Htalrh, 4, 67-77. 
17.Pfiffli,P., Hesso,A., Vainio,H. and Hyvönen,M. (1981) 4-Vinylpheool 
excretion suggestive of arene oxide fonnation in workers occupationally 
exposcd to styreoe. ToxiccL A.ppL Pharmaccl., 60, BS-90. 
18. V odicka,P. and Hemminki.IC (1988) Identification of alkylation products of 
styrene oxide in single- and double-strandcd DNA. Carcinogme.ris, 9, 
1657-1660. 
19. Bergman,K. (1982) Reactioos of vinyt cbloride with RNA and DNA of varioos 
mause tissues in vim. A.rch.. Taricol., 49, 117-129. 
20.Gold,L.S., Sawyer,C.B., Magaw,R., Backman,G.M., deVcciana,M., 
Lcvinson,R., Hooper,N.K., Havender,W.R., Bemstein,L., Peto,R., 
Pike,M.C. and Amcs,B.N. (1984) A carcinogenic potency data base of the 
standardized results of anima1 bioassays. Environ. Heallh Peryp«t., 58, 
9-319. 
R«eived on ~r 6, 1992; revi.sed 011 November 23, 1992; accepred on 
N~r26,1992 
360 
